168 related articles for article (PubMed ID: 27846727)
1. [Current Progresses in Developing PET Radiopharmaceuticals for Patients in the Czech Republic].
Adam J; Demlová R; Řehák Z
Klin Onkol; 2016; 29 Suppl 4():S95-100. PubMed ID: 27846727
[TBL] [Abstract][Full Text] [Related]
2. Development and use of non-FDG PET radiopharmaceuticals at the Masaryk Memorial Cancer Institute.
Adam J; Bolcak K; Kaderavek J; Kuzel F
Klin Onkol; 2012; 25 Suppl 2():2S82-6. PubMed ID: 23581022
[TBL] [Abstract][Full Text] [Related]
3. [New radiopharmaceuticals and positron-emission tomography applications at the Masaryk Memorial Cancer Institute in Brno].
Adam J; Andres P; Bolcák K; Cermáková M; Demlová R; Dubská L; Sedlácková S; Valík D
Klin Onkol; 2009; 22(3):94-7. PubMed ID: 19708542
[TBL] [Abstract][Full Text] [Related]
4. Acetylsalicylic Acid and its Potential for Chemoprevention of Colorectal Carcinoma.
Podhorec J; Hrstka R; Bílek O; Tuček Š; Navrátil J; Michalová E; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):77-81. PubMed ID: 31023028
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
[TBL] [Abstract][Full Text] [Related]
7. [Can we Observe Ethnic Difference in Basic Blood Tests? Single-institution Data from Cancer Prevention Programme in the Czech Republic].
Řiháček M; Valík D; Vyzula R; Zdražilová Dubská L
Klin Onkol; 2017; 30(Supplementum1):170-173. PubMed ID: 28471198
[TBL] [Abstract][Full Text] [Related]
8. An Exposition of
Saxena P; Mahmood T; Dixit M; Gambhir S; Ahsan F
Curr Radiopharm; 2021; 14(2):92-100. PubMed ID: 33261547
[TBL] [Abstract][Full Text] [Related]
9. Possible Usage of p63 in Bioptic Diagnostics.
Galoczová M; Nenutil R; Coates P; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):27-31. PubMed ID: 31023021
[TBL] [Abstract][Full Text] [Related]
10. [New Technologies for In Vivo Cancer Diagnostics].
Hernychova L; Coufalová D; Michalova E; Nenutil R; Vojtěšek B
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):88-94. PubMed ID: 27846726
[TBL] [Abstract][Full Text] [Related]
11. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
13. Preoperative evaluation of 54 gliomas by PET with fluorine-18-fluorodeoxyglucose and/or carbon-11-methionine.
Kaschten B; Stevenaert A; Sadzot B; Deprez M; Degueldre C; Del Fiore G; Luxen A; Reznik M
J Nucl Med; 1998 May; 39(5):778-85. PubMed ID: 9591574
[TBL] [Abstract][Full Text] [Related]
14. 18F fluoroethylations: different strategies for the rapid translation of 11C-methylated radiotracers.
Wadsak W; Mien LK; Ettlinger DE; Eidherr H; Haeusler D; Sindelar KM; Keppler BK; Dudczak R; Kletter K; Mitterhauser M
Nucl Med Biol; 2007 Nov; 34(8):1019-28. PubMed ID: 17998107
[TBL] [Abstract][Full Text] [Related]
15. Palladium(0)-mediated rapid methylation and fluoromethylation on carbon frameworks by reacting methyl and fluoromethyl iodide with aryl and alkenyl boronic acid esters: useful for the synthesis of [11C]CH(3)--C- and [18F]FCH2--C-Containing PET tracers (PET=positron emission tomography).
Doi H; Ban I; Nonoyama A; Sumi K; Kuang C; Hosoya T; Tsukada H; Suzuki M
Chemistry; 2009; 15(16):4165-71. PubMed ID: 19283823
[TBL] [Abstract][Full Text] [Related]
16. PET tracers in musculoskeletal disease beyond FDG.
Wieder HA; Pomykala KL; Benz MR; Buck AK; Herrmann K
Semin Musculoskelet Radiol; 2014 Apr; 18(2):123-32. PubMed ID: 24715445
[TBL] [Abstract][Full Text] [Related]
17. Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas.
Borbély K; Nyáry I; Tóth M; Ericson K; Gulyás B
J Neurol Sci; 2006 Jul; 246(1-2):85-94. PubMed ID: 16603193
[TBL] [Abstract][Full Text] [Related]
18. Determination of residual Kryptofix 2.2.2 levels in [18F]-labeled radiopharmaceuticals for human use.
Scott PJ; Kilbourn MR
Appl Radiat Isot; 2007 Dec; 65(12):1359-62. PubMed ID: 17582776
[TBL] [Abstract][Full Text] [Related]
19. [Molecular Mechanisms of Carcinogenesis of Epithelial Ovarian Cancers].
Müllerová Z; Müller T; Křivánková K; Vojtěšek B; Müller P
Klin Onkol; 2016; 29 Suppl 4(Suppl 4):46-53. PubMed ID: 27846720
[TBL] [Abstract][Full Text] [Related]
20. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
